Progressive bulbar palsy

From WikiMD's WELLNESSPEDIA


Progressive bulbar palsy
Synonyms Bulbar palsy
Pronounce N/A
Specialty N/A
Symptoms Dysarthria, dysphagia, tongue atrophy, fasciculations
Complications Aspiration pneumonia, malnutrition
Onset Typically in adulthood
Duration Progressive
Types
Causes Neurodegenerative disease
Risks
Diagnosis Clinical diagnosis, Electromyography
Differential diagnosis Myasthenia gravis, stroke, brainstem tumor
Prevention N/A
Treatment Supportive care, speech therapy, nutritional support
Medication
Prognosis Poor, progressive
Frequency Rare
Deaths N/A


Progressive Bulbar Palsy (PBP) is a disease that affects the nerves supplying the bulbar muscles. These muscles are responsible for swallowing, speaking, and breathing. PBP is a type of motor neuron disease.

Symptoms[edit]

The symptoms of PBP can vary, but they often include difficulty swallowing (dysphagia), slurred speech (dysarthria), and weakness in the facial muscles. Other symptoms can include emotional lability, where the person has uncontrollable bouts of laughing or crying, and difficulty with tongue movements.

Causes[edit]

PBP is caused by the degeneration of motor neurons in the brainstem. The exact cause of this degeneration is unknown, but it is thought to be related to a combination of genetic and environmental factors.

Diagnosis[edit]

Diagnosis of PBP is based on the symptoms, medical history, and a physical examination. Tests such as electromyography (EMG) and nerve conduction studies may be used to confirm the diagnosis.

Treatment[edit]

There is currently no cure for PBP, but treatment can help manage symptoms. This can include speech therapy, physical therapy, and medications to control symptoms such as spasticity and excessive salivation.

Prognosis[edit]

The prognosis for PBP is generally poor, with most people dying within 2-3 years of diagnosis. However, some people may live longer with supportive care.

See also[edit]


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.